Oncimmune Holdings plc
ONC.L · LSE
8/31/2024 | 8/31/2023 | 5/31/2022 | 5/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£4,105 | -£6,151 | -£9,529 | -£5,696 |
| Dep. & Amort. | £263 | £981 | £1,429 | £740 |
| Deferred Tax | £0 | £0 | -£409 | -£379 |
| Stock-Based Comp. | £482 | -£1,182 | £1,800 | £1,046 |
| Change in WC | -£93 | -£23 | -£445 | -£965 |
| Other Non-Cash | £72 | -£416 | £943 | £727 |
| Operating Cash Flow | -£3,381 | -£6,791 | -£6,211 | -£4,527 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£9 | -£31 | -£504 | -£1,071 |
| Net Acquisitions | £0 | £39 | £0 | £215 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £1,170 | £11,575 | £0 | £215 |
| Investing Cash Flow | £1,161 | £11,583 | -£504 | -£856 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | -£4,885 | £998 | £1,593 |
| Stock Issued | £5 | £2,095 | £142 | £8,489 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£76 | -£225 | -£153 | -£303 |
| Financing Cash Flow | -£71 | -£3,015 | £987 | £9,779 |
| Forex Effect | -£72 | £7 | -£375 | -£5 |
| Net Chg. in Cash | -£2,363 | £1,784 | -£6,103 | £4,391 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £3,209 | £1,425 | £8,631 | £4,240 |
| End Cash | £846 | £3,209 | £2,528 | £8,631 |
| Free Cash Flow | -£3,390 | -£6,822 | -£6,715 | -£5,598 |